Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan in Persistent Atrial Fibrillation
NCT00613496Phase 4Unknown
- Sponsor
- University of Magdeburg
- Start
- May 2009
- Primary completion
- May 2010
- Countries
- 1
01
Overview
A Phase 4 trial of irbesartan in Atrial fibrillation (AFib), sponsored by University of Magdeburg. Status: unknown.
02
Drugs
irbesartan
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00613496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00613496.